Expert Review of Pharmacoeconomics & Outcomes Research, Volume 22, Issue 4 (2022)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Pharmacoeconomics & Outcomes Research, Volume 22, Issue 4 (2022)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Volume 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Special report

Article
What might have happened: the impact of interrupting entry of innovative drugs on disease outcomes in the United States
William Herring, Michael Ciarametaro, Josephine Mauskopf, David Wamble, Brian Sils & Robert Dubois
Pages: 529-541
Published online: 21 Feb 2022
AbstractforWhat might have happened: the impact of interrupting entry of innovative drugs on disease outcomes in the United States | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 1654 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Systematic Review

Cost-effectiveness of osimertinib in the treatment of advanced EGFR-mutated non-small cell lung cancer: a systematic review
Shahin Nargesi, Zeinab Dolatshahi, Aziz Rezapour, Vahid Alipour, Aghdas Souresrafil, Hiro Farabi, Seyed Arash Javadmoosavi, Mandana Safakhah & Najmeh Moradi
Pages: 543-554
Published online: 12 Dec 2021
AbstractforCost-effectiveness of osimertinib in the treatment of advanced EGFR-mutated non-small cell lung cancer: a systematic review | Full Text | References | PDF (343.7 KB) | EPUB
  • 377 Views
  • 0 CrossRef citations
  • 0Altmetric
Pharmacoeconomic evaluation of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus: a systematic literature review
Zhen Ruan, Huimin Zou, Qing Lei, Carolina Oi Lam Ung, Honghao Shi & Hao Hu
Pages: 555-574
Published online: 18 Feb 2022
AbstractforPharmacoeconomic evaluation of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus: a systematic literature review | Full Text | References | PDF (1.2 MB) | EPUB
  • 438 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Research

Article
Cost-utility analysis of dupilumab add on therapy versus standard therapy in adolescents and adults for severe asthma in Colombia
Jefferson Antonio Buendía & Diana Guerrero Patiño
Pages: 575-580
Published online: 03 Dec 2021
AbstractforCost-utility analysis of dupilumab add on therapy versus standard therapy in adolescents and adults for severe asthma in Colombia | Full Text | References | PDF (2.3 MB) | EPUB
  • 232 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Evaluating discrete choice experiment willingness to pay [DCE-WTP] analysis and relative social willingness to pay [RS-WTP] analysis in a health technology assessment of a treatment for an ultra-rare childhood disease [CLN2]
Domenico Moro, Michael Schlander, Harry Telser, Oriol Sola-Morales, Michael David Clark, Andrew Olaye, Charlotte Camp, Mohit Jain, Thomas Butt & Sumeet Bakshi
Pages: 581-598
Published online: 23 Feb 2022
AbstractforEvaluating discrete choice experiment willingness to pay [DCE-WTP] analysis and relative social willingness to pay [RS-WTP] analysis in a health technology assessment of a treatment for an ultra-rare childhood disease [CLN2] | Full Text | References | PDF (2.4 MB) | EPUB | Supplemental
  • 4267 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Five-year budget impact of a prescription digital therapeutic for patients with opioid use disorder
Fulton F. Velez, Danmeng Huang, Lorie Mody & Daniel C. Malone
Pages: 599-607
Published online: 24 Jan 2022
AbstractforFive-year budget impact of a prescription digital therapeutic for patients with opioid use disorder | Full Text | References | PDF (2.7 MB) | EPUB
  • 1780 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-consequence analysis of diagnosis and early treatment of acquired thrombotic thrombocytopenic purpura in Colombia
Yaneth Gil-Rojas & Pieralessandro Lasalvia
Pages: 609-615
Published online: 30 Dec 2021
AbstractforCost-consequence analysis of diagnosis and early treatment of acquired thrombotic thrombocytopenic purpura in Colombia | Full Text | References | PDF (259.7 KB) | EPUB | Supplemental
  • 125 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
An update on the economic burden of type 2 diabetes mellitus in China
Chunchun Ding, Yun Bao, Bona Bai, Xuerun Liu, Bingyin Shi & Limin Tian
Pages: 617-625
Published online: 30 Dec 2021
AbstractforAn update on the economic burden of type 2 diabetes mellitus in China | Full Text | References | PDF (1.3 MB) | EPUB
  • 743 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Prevalence and direct costs of potentially inappropriate prescriptions in France: a population-based study
Barbara Roux, Julien Bezin, Camille Morival, Pernelle Noize & Marie-Laure Laroche
Pages: 627-636
Published online: 24 Sep 2021
AbstractforPrevalence and direct costs of potentially inappropriate prescriptions in France: a population-based study | Full Text | References | PDF (735.4 KB) | EPUB | Supplemental
  • 129 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Cost-effectiveness analysis of the first‐line EGFR‐TKIs in patients with advanced EGFR-mutated non-small-cell lung cancer
J Aguilar-Serra, V Gimeno-Ballester, a Pastor-Clerigues, J Milara, C Trigo-Vicente & J Cortijo
Pages: 637-646
Published online: 11 Oct 2021
AbstractforCost-effectiveness analysis of the first‐line EGFR‐TKIs in patients with advanced EGFR-mutated non-small-cell lung cancer | Full Text | References | PDF (1.9 MB) | EPUB | Supplemental
  • 458 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Durvalumab consolidation therapy in patients with stage III non-small cell lung cancer after concurrent chemoradiation: a China-based cost-effectiveness analysis
Xuan Chen, Zhiguang Yang, Guiyuan Xiang, Lingna Gu, Ziheng Qi, Bin Wan, Yun Lu, Feng Chang & Yumei Zhu
Pages: 647-654
Published online: 02 Nov 2021
AbstractforDurvalumab consolidation therapy in patients with stage III non-small cell lung cancer after concurrent chemoradiation: a China-based cost-effectiveness analysis | Full Text | References | PDF (2.3 MB) | EPUB | Supplemental
  • 654 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Cost-utility of dapagliflozin plus standard treatment compared to standard treatment for the management of heart failure with reduced ejection fraction in Colombia
Yaneth Gil-Rojas, Pieralessandro Lasalvia & Ángel García
Pages: 655-663
Published online: 16 Nov 2021
AbstractforCost-utility of dapagliflozin plus standard treatment compared to standard treatment for the management of heart failure with reduced ejection fraction in Colombia | Full Text | References | PDF (988.2 KB) | EPUB | Supplemental
  • 1763 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article
Chronic inflammatory demyelinating polyneuropathy in Spain: a retrospective analysis of hospital incidence and medical costs
Josep Darbà & Alicia Marsà
Pages: 665-670
Published online: 10 Nov 2021
AbstractforChronic inflammatory demyelinating polyneuropathy in Spain: a retrospective analysis of hospital incidence and medical costs | Full Text | References | PDF (757.7 KB) | EPUB
  • 124 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Budget impact and pharmacy costs with targeted use of oliceridine for postsurgical pain in patients at high risk of opioid-related adverse events
Kit N Simpson, Michael J Fossler, Linda Wase, Mark A Demitrack & Todd L Wandstrat
Pages: 671-681
Published online: 15 Mar 2022
AbstractforBudget impact and pharmacy costs with targeted use of oliceridine for postsurgical pain in patients at high risk of opioid-related adverse events | Full Text | References | PDF (316.8 KB) | EPUB | Supplemental
  • 1880 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Article
Economic burden of comorbidities among COPD Patients hospitalized for acute exacerbations: an analysis of a commercially insured population
Chintal H. Shah, Eberechukwu Onukwugha, Zafar Zafari, Ester Villalonga-Olives, Jeong-eun Park & Julia F. Slejko
Pages: 683-690
Published online: 24 Sep 2021
AbstractforEconomic burden of comorbidities among COPD Patients hospitalized for acute exacerbations: an analysis of a commercially insured population | Full Text | References | PDF (792.1 KB) | EPUB | Supplemental
  • 225 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
In-hospital economic burden of anastomotic leakage after colorectal anastomosis surgery: a real-world cost analysis in Italy
Gabriella Teresa Capolupo, Thibaut Galvain, Vito Paragò, Cyndy Tong, Gianluca Mascianà, Stefano Di Berardino, Damiano Caputo, Vincenzo La Vaccara & Marco Caricato
Pages: 691-697
Published online: 01 Dec 2021
AbstractforIn-hospital economic burden of anastomotic leakage after colorectal anastomosis surgery: a real-world cost analysis in Italy | Full Text | References | PDF (334.3 KB) | EPUB
  • 169 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Assessing smoking cessation services and pharmacotherapy in Namibia: findings and implications for future policy initiatives
Ester Hango, Kristofina Amakali, Anna Shilunga, Dan Kibuule, Brian Godman & Francis Kalemeera
Pages: 699-710
Published online: 08 Dec 2021
AbstractforAssessing smoking cessation services and pharmacotherapy in Namibia: findings and implications for future policy initiatives | Full Text | References | PDF (3 MB) | EPUB
  • 103 Views
  • 1 CrossRef citations
  • 0Altmetric

Explore articles